These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


225 related items for PubMed ID: 11917061

  • 1. Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up.
    Segarra A, Vila J, Pou L, Majó J, Arbós A, Quiles T, Piera LL.
    Nephrol Dial Transplant; 2002 Apr; 17(4):655-62. PubMed ID: 11917061
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [Abstract] [Full Text] [Related]

  • 3. Combination of immunosuppressive agents in treatment of steroid-resistant minimal change disease and primary focal segmental glomerulosclerosis.
    El-Reshaid K, El-Reshaid W, Madda J.
    Ren Fail; 2005 May; 27(5):523-30. PubMed ID: 16152989
    [Abstract] [Full Text] [Related]

  • 4. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J.
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [Abstract] [Full Text] [Related]

  • 5. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
    Mahmoud I, Basuni F, Sabry A, El-Husseini A, Hassan N, Ahmad NS, Elbaz M, Moustafa F, Sobh M.
    Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of combined cyclosporin A and mycophenolate mofetil therapy in patients with cyclosporin-resistant focal segmental glomerulosclerosis.
    Segarra Medrano A, Vila Presas J, Pou Clavé L, Majó Masferrer J, Camps Doménech J.
    Nefrologia; 2011 Apr; 31(3):286-91. PubMed ID: 21468162
    [Abstract] [Full Text] [Related]

  • 7. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.
    Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL.
    Kidney Int; 1999 Dec; 56(6):2220-6. PubMed ID: 10594798
    [Abstract] [Full Text] [Related]

  • 8. Cyclosporine-based immunosuppressive therapy for patients with steroid-resistant focal segmental glomerulosclerosis: a meta-analysis.
    Chiou YY, Lee YC, Chen MJ.
    Curr Med Res Opin; 2017 Aug; 33(8):1389-1399. PubMed ID: 28436233
    [Abstract] [Full Text] [Related]

  • 9. Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial.
    Ren H, Shen P, Li X, Pan X, Zhang W, Chen N.
    Am J Nephrol; 2013 Aug; 37(1):84-90. PubMed ID: 23343906
    [Abstract] [Full Text] [Related]

  • 10. Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide.
    Hari P, Bagga A, Jindal N, Srivastava RN.
    Pediatr Nephrol; 2001 Nov; 16(11):901-5. PubMed ID: 11685598
    [Abstract] [Full Text] [Related]

  • 11. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
    Gellermann J, Ehrich JH, Querfeld U.
    Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
    [Abstract] [Full Text] [Related]

  • 12. Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis.
    Heering P, Braun N, Müllejans R, Ivens K, Zäuner I, Fünfstück R, Keller F, Krämer BK, Schollmeyer P, Risler T, Grabensee B, German Collaborative Glomerulonephritis Study Group.
    Am J Kidney Dis; 2004 Jan; 43(1):10-8. PubMed ID: 14712422
    [Abstract] [Full Text] [Related]

  • 13. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy.
    Duncan N, Dhaygude A, Owen J, Cairns TD, Griffith M, McLean AG, Palmer A, Taube D.
    Nephrol Dial Transplant; 2004 Dec; 19(12):3062-7. PubMed ID: 15507477
    [Abstract] [Full Text] [Related]

  • 14. Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome.
    Westhoff TH, Schmidt S, Zidek W, Beige J, van der Giet M.
    Clin Nephrol; 2006 Jun; 65(6):393-400. PubMed ID: 16792133
    [Abstract] [Full Text] [Related]

  • 15. A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children.
    Lieberman KV, Tejani A.
    J Am Soc Nephrol; 1996 Jan; 7(1):56-63. PubMed ID: 8808110
    [Abstract] [Full Text] [Related]

  • 16. Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children.
    Gulati S, Prasad N, Sharma RK, Kumar A, Gupta A, Baburaj VP.
    Nephrol Dial Transplant; 2008 Mar; 23(3):910-3. PubMed ID: 18039644
    [Abstract] [Full Text] [Related]

  • 17. Steroid resistant focal segmental glomerulosclerosis: effect of arterial hyalinosis on outcome: single center study.
    Soliman AR, Maamoun H, Soliman H, Ahmed RM.
    Rom J Intern Med; 2021 Jun 01; 59(2):127-133. PubMed ID: 33565308
    [Abstract] [Full Text] [Related]

  • 18. Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis?
    Ponticelli C, Villa M, Banfi G, Cesana B, Pozzi C, Pani A, Passerini P, Farina M, Grassi C, Baroli A.
    Am J Kidney Dis; 1999 Oct 01; 34(4):618-25. PubMed ID: 10516340
    [Abstract] [Full Text] [Related]

  • 19. Tacrolimus is an alternative therapy option for the treatment of adult steroid-resistant nephrotic syndrome: a prospective, multicenter clinical trial.
    Fan L, Liu Q, Liao Y, Li Z, Ji Y, Yang Z, Chen J, Fu J, Zhang J, Kong Y, Fu P, Lou T, Liu Z, Yu X, Chen W.
    Int Urol Nephrol; 2013 Apr 01; 45(2):459-68. PubMed ID: 22684795
    [Abstract] [Full Text] [Related]

  • 20. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
    Greig P, Lilly L, Scudamore C, Erb S, Yoshida E, Kneteman N, Bain V, Ghent C, Marotta P, Grant D, Wall W, Tchervenkov J, Barkun J, Roy A, Marleau D, McAlister V, Peltekian K.
    Liver Transpl; 2003 Jun 01; 9(6):587-95. PubMed ID: 12783400
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.